Knowledge

In a field as sensitive as monoclonal antibody development and production, controlled processes and procedures have always played a vital role and will continue to do so. Learn more why Single-use technologies are highly flexible, scalable and on another quality level.

Putting cell & gene therapies into practice requires complex logistics. Our new eBook will show you solutions to simplify complex process logistics.

Single-use Technology - New biopharmaceutical drug products that alter and even save lives can be very profitable for their developers - download white paper!

Irrespective of what industry we are talking about, the term end-to-end solution describes a principle that takes a system or service – from beginning to end – and delivers a complete functional solution.
 

In this article we talk about the bulk filtration process in the biopharma industry. We talk about the industries hurdles and why single use components are the future. Learn more why SUSupport has the solution!

Automated filling systems are recommended by many market experts to reach the next level in drug substance management. In this article you will find out why and how the end-to-end solution by SUSupport is also your solution!
 

Only the combination of single use bags and RoSS shells increased the storage density due to its rectangular geometry and its possibility to stack. Learn more – [including podcast episodes]
 

Labs and manufacturers feel the pressure to deliver at a constantly accelerating pace while remaining flexible. In this article, you will learn how Single Use Support can bring you to the next level!

Read more about CAR-T cell therapy, its history and hurdles. Learn also how Single Use Support can support this novel therapy with great potential!

The case study depicts how the implementation of Single Use Support and CPC products positively impacted on the performance of the company. Get the case study now & listen to free podcasts!

The term CGT stands for Cell and Gene Therapy and describes a range of new personalized therapies that are promising in the treatment of some diseases. For which diseases is the therapy suitable?

The big names in the pharmaceutical industry are increasingly switching from immobile systems based on bulky stainless steel tankers to scalable single-use filtration systems. But why is this so?